Liquid Phase Peptide Synthesis Sector: Growth Drivers and Challenges
Growth Drivers
-
Advancement in Technology – Continuous Advancement in Liquid-phase synthesis methods, such as automated peptide synthesizers and novel coupling chemistries, enhance efficiency and scalability, thereby driving the market’s growth.
- Expanding Applications- Diversification of peptide synthesis applications beyond pharmaceuticals, including diagnostics, cosmetics, and research purposes, broadens the market scope and drives growth.
- Rising Research & Development Activities- Expanded research activities in pharmaceuticals and biotechnology, focusing on developing new peptide-based drugs, stimulate the demand for liquid-phase peptide techniques. For instance, it is reported that one-pot liquid phase peptide synthesis process that involves adding amino acids to a "nanostar" support iteratively and using organic solvent nanofiltration (OSN) to isolate the developing peptide at the end of each synthesis cycle.This made it possible to synthesize peptides more effectively while keeping all of the advantages of liquid phase synthesis. First, enkephalin-like model penta- and decapeptides were synthesized, followed by octreotate amide, and ultimately octreotate, in order to verify PEPSTAR. In comparison to vendor-produced samples from solid phase synthesis, the crude purities compared satisfactorily.
- Government Initiatives- Supportive regulatory policies and funding initiatives by the government to promote peptide-based drug development encourage market growth by fostering innovation and investment in Liquid-phase peptide synthesis technology.
Challenges
-
Complexity in sequence design- peptide synthesis can be complex due to the diversity of peptide sequences desired. Designing and optimizing sequences for desired properties can be challenging.
- Liquid peptide synthesis can be expensive to plot a large-scale plant.
- Different amino acids have varying reactivity and compatibility, making it challenging to find suitable reaction conditions for diverse sequences without side reactions or impurities.
Liquid Phase Peptide Synthesis Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
10.1% |
|
Base Year Market Size (2024) |
USD 5.51 billion |
|
Forecast Year Market Size (2037) |
USD 19.25 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of liquid phase peptide synthesis is estimated at USD 5.98 billion.
The liquid phase peptide synthesis market size was over USD 5.51 billion in 2024 and is poised to exceed USD 19.25 billion by 2037, witnessing over 10.1% CAGR during the forecast period i.e., between 2025-2037. Growing demand for peptide-based therapeutics, expanding applications, research and development, and supportive government policies will boost the market growth.
North America industry is predicted to dominate majority revenue share of 42% by 2037, fueled by robust research and development activities, the region witnesses extensive utilization of peptides in drug discovery and development by pharmaceutical giants and biotechnology firms.
The major players in the market are CEM Corporation, Bachem AG, CSBio, Biotage, AnaSpec, ZenBio, Inc., Thermo Fisher Scientific Inc., GenScript, PolyPeptide Group, Sosei Group Corporation, Tokyo Mirai Style Co., Ltd., and others.